GlassScriptPhysician profile
Benjamin David Elgamil
NPI 1831539303
$1,947.11
in general payments reported to CMS, 2019-2025
15 companies · $206 in 2025
The $206 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2021: $29.90 · 2022: $1,391 · 2023: $154 · 2024: $49.52 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $409.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $409.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supreme Orthopedic Systems, LLC | $1,220.65 | 2022 | |
| Smith+Nephew, INC. | $231.02 | 2019-2023 | Renasys Go V2 Home, Pico 7 |
| Treace Medical Concepts, INC. | $189.92 | 2025 | |
| Nevro Corp. | $60.26 | 2022-2024 | Senza |
| Stryker Corporation | $48.23 | 2023 | Anchorage |
| Sebela Pharmaceuticals INC. | $31.19 | 2022-2023 | Naftin |
| Organogenesis INC. | $30.98 | 2023 | Puraply |
| Convatec INC. | $21.54 | 2023 | |
| Depuy Synthes Sales INC. | $21.05 | 2022 | |
| Triad Life Sciences INC. | $20.98 | 2022 | |
| Ets Wound Care LLC | $16.58 | 2024 | Mirragen Advanced Wound Matrix |
| Globus Medical, INC. | $15.83 | 2025 | Senza |
| Mimedx Group, INC. | $13.67 | 2024 | |
| Horizon Therapeutics Plc | $13.07 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $12.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Elgamil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.